Joseph J. Schildkraut

11.0k total citations · 2 hit papers
121 papers, 8.1k citations indexed

About

Joseph J. Schildkraut is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Joseph J. Schildkraut has authored 121 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Cellular and Molecular Neuroscience, 34 papers in Psychiatry and Mental health and 30 papers in Pharmacology. Recurrent topics in Joseph J. Schildkraut's work include Neurotransmitter Receptor Influence on Behavior (39 papers), Treatment of Major Depression (29 papers) and Neuroscience and Neuropharmacology Research (25 papers). Joseph J. Schildkraut is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (39 papers), Treatment of Major Depression (29 papers) and Neuroscience and Neuropharmacology Research (25 papers). Joseph J. Schildkraut collaborates with scholars based in United States, Czechia and United Kingdom. Joseph J. Schildkraut's co-authors include Seymour S. Kety, Irwin J. Kopin, Saul M. Schanberg, Paul J. Orsulak, George R. Breese, Edna K. Gordon, Ernest Hartmann, Jack Durell, Geraldine Cassens and Alan F. Schatzberg and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Joseph J. Schildkraut

118 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE

1965 2.5k citations Joseph J. Schildkraut American Journal of Psychiatry profile →
Biogenic Amines and Emotion

1967 650 citations Joseph J. Schildkraut et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph J. Schildkraut United States	42	3.5k	2.1k	1.9k	1.4k	1.4k	121	8.1k
James W. Maas United States	48	2.4k 0.7×	2.0k 0.9×	1.3k 0.7×	1.3k 0.9×	867 0.6×	139	6.6k
David S. Janowsky United States	45	2.7k 0.8×	1.5k 0.7×	1.2k 0.7×	1.7k 1.2×	656 0.5×	213	6.8k
Alan Frazer United States	56	4.8k 1.4×	1.6k 0.7×	1.7k 0.9×	3.0k 2.1×	1.2k 0.9×	211	10.3k
Alec Coppen United Kingdom	54	2.1k 0.6×	3.7k 1.7×	2.6k 1.4×	1.1k 0.7×	1.8k 1.3×	219	9.8k
Samuel Gershon United States	55	3.9k 1.1×	4.9k 2.3×	2.1k 1.1×	2.1k 1.5×	981 0.7×	385	11.8k
H. Beckmann Germany	44	2.6k 0.7×	2.6k 1.2×	861 0.5×	1.6k 1.1×	920 0.7×	254	7.9k
David Pickar United States	44	2.1k 0.6×	2.5k 1.2×	852 0.5×	859 0.6×	1.2k 0.9×	135	6.5k
Mike Briley France	42	4.7k 1.4×	1.3k 0.6×	1.9k 1.0×	2.7k 1.9×	1.1k 0.8×	121	11.0k
Bernard Lerer Israel	58	2.9k 0.8×	4.3k 2.0×	1.9k 1.0×	2.8k 1.9×	1.4k 1.0×	339	12.6k
David Copolov Australia	51	2.3k 0.7×	3.8k 1.8×	852 0.5×	1.7k 1.2×	1.5k 1.1×	242	9.3k

Countries citing papers authored by Joseph J. Schildkraut

Since Specialization

Citations

This map shows the geographic impact of Joseph J. Schildkraut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph J. Schildkraut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph J. Schildkraut more than expected).

Fields of papers citing papers by Joseph J. Schildkraut

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph J. Schildkraut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph J. Schildkraut. The network helps show where Joseph J. Schildkraut may publish in the future.

Co-authorship network of co-authors of Joseph J. Schildkraut

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph J. Schildkraut. A scholar is included among the top collaborators of Joseph J. Schildkraut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph J. Schildkraut. Joseph J. Schildkraut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mooney, John J., et al.. (2013). Increased Gsα within blood cell membrane lipid microdomains in some depressive disorders: An exploratory study. Journal of Psychiatric Research. 47(6). 706–711. 7 indexed citations

Canuso, Carla M., Jill M. Goldstein, Joanne Wojcik, et al.. (2002). Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatry Research. 111(1). 11–20. 73 indexed citations

Schildkraut, Joseph J.. (2000). Beyond Reason: Art and Psychosis: Works From the Prinzhorn Collection. American Journal of Psychiatry. 157(12). 2068–a. 2 indexed citations

Schildkraut, Joseph J., et al.. (1996). Depression and the spiritual in modern art : homage to Miró. John Wiley eBooks. 8 indexed citations

Schildkraut, Joseph J., et al.. (1995). Should Clozapine Be a First-line Treatment for Schizophrenia? The Rationale for a Double-Blind Clinical Trial in First-Episode Patients. Harvard Review of Psychiatry. 3(1). 1–9. 36 indexed citations

Green, Alan, et al.. (1993). Haloperidol response and plasma catecholamines and their metabolites. Schizophrenia Research. 10(1). 33–37. 30 indexed citations

Bloomingdale, Kerry, Russell G. Vasile, Jon E. Gudeman, Benjamin Gerson, & Joseph J. Schildkraut. (1986). The dexamethasone suppression test (DST) and platelet monoamine oxidase (MAO) activity as predictors of psychosis in depression. Biological Psychiatry. 21(4). 390–393. 4 indexed citations

Schatzberg, Alan F., Alan Rosenbaum, Paul J. Orsulak, et al.. (1981). Toward a biochemical classification of depressive disorders. Psychopharmacology. 75(1). 34–38. 86 indexed citations

Orsulak, Paul J., et al.. (1980). The effects of tranylcypromine isomers on norepinephrine-H3 metabolism in rat brain. Psychopharmacology. 69(2). 193–199. 14 indexed citations

10.

Orsulak, Paul J., et al.. (1978). Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 13(6). 637–47. 42 indexed citations

11.

Schildkraut, Joseph J., et al.. (1976). Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients. American Journal of Psychiatry. 133(4). 438–440. 75 indexed citations

12.

Schildkraut, Joseph J.. (1974). Biochemical Criteria for Classifying Depressive Disorders and Predicting Responses to Pharmacotherapy: Preliminary Findings from Studies of Norepinephrine Metabolism. Pharmacopsychiatry. 7(2). 98–107. 12 indexed citations

13.

Schildkraut, Joseph J., et al.. (1971). Changes in Norepinephrine Turnover in Rat Brain During Chronic Administration of Imipramine and Protriptyline: A Possible Explanation for the Delay in Onset of Clinical Antidepressant Effects. American Journal of Psychiatry. 127(8). 1032–1039. 58 indexed citations

14.

Schildkraut, Joseph J.. (1970). Neurochemical Studies of the Affective Disorders: The Pharmacological Bridge. American Journal of Psychiatry. 127(3). 358–360. 4 indexed citations

15.

Schildkraut, Joseph J., Irwin J. Kopin, Saul M. Schanberg, & Jack Durell. (1968). Norepinephrine Metabolism and Psychoactive Drugs in the Endogenous Depressions^*^**. Pharmacopsychiatry. 1(2). 69–92. 7 indexed citations

16.

Schanberg, Saul M., George R. Breese, Joseph J. Schildkraut, Edna K. Gordon, & Irwin J. Kopin. (1968). 3-Methoxy-4-hydroxyphenylglycol sulfate in brain and cerebrospinal fluid. Biochemical Pharmacology. 17(9). 2006–2008. 190 indexed citations

17.

Schanberg, Saul M., Joseph J. Schildkraut, & Irwin J. Kopin. (1967). THE EFFECTS OF PENTOBARBITAL ON THE FATE OF INTRACISTERNALLY ADMINISTERED NOREPINEPHRINE-H3. Journal of Pharmacology and Experimental Therapeutics. 157(2). 311–318. 105 indexed citations

18.

Schildkraut, Joseph J., Saul M. Schanberg, George R. Breese, & Irwin J. Kopin. (1967). Norepinephrine Metabolism and Drugs Used in the Affective Disorders: A Possible Mechanism of Action. American Journal of Psychiatry. 124(5). 600–608. 98 indexed citations

19.

Stevens, George C., et al.. (1965). Das tagebuch der Anne Frank. Fischer Taschenbuch eBooks. 1 indexed citations

20.

Schildkraut, Joseph J., et al.. (1959). My father and I. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact